Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging
A legfontosabb adatok
- Ki végzi
- Genesis Research LLC
- Hol
- San Diego (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Leállítva
- Résztvevők
- 4 fő vett részt
- Kezdés
- 2023. máj. 30.
- Befejezés
- 2024. dec. 5.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- TRANBERG®|Thermal Therapy System
- A regiszteradat frissítve
- 2024. december 10.
- Miért állt le
- Business decision of the Sponsor
Ki vehet részt
- Életkor
- 40 év – 85 év
- Nem
- Csak férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 21 feltétel megnézéseKevesebb
Ki vehet részt
- Men between the ages of 40 and 85 years
- Ability to read, understand and agree/sign the patient informed consent in the English language
- Serum PSA < 20 ng/ml
- AJCC clinical tumor stage T2b or less (according to digital rectal examination)
- Men with localized PCa (GG 1or 2, Gleason Score 7 or less) (Low or Favorable Intermediate Risk PCa) with an MR-image detected index lesion done within three months from the time of enrollment and visible on micro-ultrasound
- According to the decision of the investigator:; Patient is suitable to undergo treatment with FLA; Able to tolerate a procedure under local anesthesia; Able to undergo Nitrous Oxide sedation; Able to undergo MR; has normal rectal anatomy
- Lesion Specificity:; Unilateral, with cumulative lesion volumes not comprising more than 50 percent of the lobe as determined by MRI; Lesion distances from the outer perimeter of the energy emitting zone of the diffuser to adjacent vital structures (bladder wall, rectal wall, neurovascular bundles, and urethra) must be ≥ 8mm
- Minimum distance to rectal wall and other sensitive structures ≥ 8mm
Ki nem vehet részt
- Previous prostate surgery
- Anticoagulant therapy
- Prior or ongoing PCa treatment including surgery, radiation therapy, hormonal therapy or focal therapy
- Previous radiation of the pelvic region
- Patients with recurrent prostate cancer
- Gleason Grade Group 3 PCa or higher
- Multifocal PCa other than Gleason Grade Group 1
- Locally advanced or metastatic PCa
- Intraprostatic calculus > 5mm
- Inability to tolerate a dorsal lithotomy position under Nitrous Oxide sedation for > 90 minutes
- ECOG Status ≥2
- Urethral Stenosis
- Prostate height > 5 cm anterior to posterior or a prostate volume >100 cc's
Helyszínek itt: Egyesült Államok
- Genesis Research, LLCSan Diego, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
Trans-perineal focal laser ablation represents a promising alternative focal therapy option for patients with low-risk or favorable intermediate risk prostate cancer. FLA has been extensively utilized for over a decade in the treatment of PCa using different anatomical approaches. The proposed study differs from past ones in that a trans-perineal approach with reduced risk of infection will be used in contrast to the current trans-rectal approach. In addition, high frequency micro-ultrasound imaging will be used to enhance imaging and facilitate accurate needle placement and FLA of the index lesions.
A teljes eredeti leírásKevesebb
The aim of this study is to evaluate FLA as a potential optimal therapeutic intervention based on safety, ease of use, efficacy, and cost.1 FLA holds promise for the management of localized tumors. The combination of the trans-perineal focal laser ablation and micro-ultrasound imaging will enable targeted trans-perineal fusion laser induced thermal therapy of prostate cancer lesions. This approach offers significant potential advantages over traditional interventions including:
* Improved dynamic ultrasound imaging of the lesion to be treated compared to traditional ultrasound techniques. * Enhanced ability to visualize and spare critical structures within the prostate, including the bladder neck, neurovascular bundle (NVB), urethral sphincter and organs in close proximity including the rectum. * Sparing these structures should translate into improved preservation of ejaculation, limited changes in sexual function and minimal transient incontinence following treatment.
A vizsgálat csoportja
- Laser AblationA vizsgált kezelés
TRANBERG® Transperineal Micro Ultrasound guided laser ablation of Prostate Cancer.
Kezelés: TRANBERG®|Thermal Therapy System
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2024. december 10.